Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Erythropoietin ameliorates rat experimental autoimmune neuritis by inducing transforming growth factor-β in macrophages.

Mausberg AK, Meyer Zu Hörste G, Dehmel T, Stettner M, Lehmann HC, Sheikh KA, Kieseier BC.

PLoS One. 2011;6(10):e26280. doi: 10.1371/journal.pone.0026280. Epub 2011 Oct 17.

2.

Erythropoietin is a hypoxia inducible factor-induced protective molecule in experimental autoimmune neuritis.

Luo B, Jiang M, Yang X, Zhang Z, Xiong J, Schluesener HJ, Zhang Z, Wu Y.

Biochim Biophys Acta. 2013 Aug;1832(8):1260-70. doi: 10.1016/j.bbadis.2013.04.015. Epub 2013 Apr 17.

3.

IFN-beta suppresses experimental autoimmune neuritis in Lewis rats by inhibiting the migration of inflammatory cells into peripheral nervous tissue.

Zou LP, Ma DH, Wei L, van der Meide PH, Mix E, Zhu J.

J Neurosci Res. 1999 Apr 15;56(2):123-30.

PMID:
10494101
4.

Upregulation of erythropoietin in rat peripheral nervous system with experimental autoimmune neuritis.

Ahn M, Moon C, Jeong C, Matsumoto Y, Koh CS, Shin T.

Brain Res. 2010 May 28;1333:82-90. doi: 10.1016/j.brainres.2010.03.072. Epub 2010 Mar 31.

PMID:
20361946
5.

Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.

Jung S, Schluesener HJ, Schmidt B, Fontana A, Toyka KV, Hartung HP.

Immunology. 1994 Dec;83(4):545-51.

7.

Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection.

Liu Y, Luo B, Han F, Li X, Xiong J, Jiang M, Yang X, Wu Y, Zhang Z.

PLoS One. 2014 Mar 6;9(3):e90942. doi: 10.1371/journal.pone.0090942. eCollection 2014. Erratum in: PLoS One. 2014;9(5):e99555. Dosage error in article text.

8.

MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis.

Zhang ZY, Zhang Z, Schluesener HJ.

Neuroscience. 2010 Aug 11;169(1):370-7. doi: 10.1016/j.neuroscience.2010.04.074. Epub 2010 May 6.

PMID:
20451583
9.

Treatment with P2 protein peptide 57-81 by nasal route is effective in Lewis rat experimental autoimmune neuritis.

Zou LP, Zhu J, Deng GM, Levi M, Wahren B, Diab A, Hillert J, Link H.

J Neuroimmunol. 1998 May 15;85(2):137-45.

PMID:
9630162
10.
11.

Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.

Jung S, Gaupp S, Korn T, Köllner G, Hartung HP, Toyka KV.

J Neurosci Res. 2004 Feb 15;75(4):524-35.

PMID:
14743436
12.

Antigen-specific immunosuppression: nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats.

Zou LP, Ma DH, Levi M, Wahren B, Wei L, Mix E, van der Meide PH, Link H, Zhu J.

J Neuroimmunol. 1999 Feb 1;94(1-2):109-21.

PMID:
10376943
13.

Erythropoietin attenuates the development of experimental autoimmune myocarditis.

Hirose S, Takahashi M, Ogawa R, Morimoto H, Izawa A, Sato H, Ise H, Hongo M, Ikeda U.

Cardiovasc Drugs Ther. 2007 Feb;21(1):17-27. Epub 2007 Feb 13.

PMID:
17297593
14.

Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.

Zhu J, Deng GM, Levi M, Wahren B, Diab A, van der Meide PH, Link H.

J Neuropathol Exp Neurol. 1998 Mar;57(3):291-301.

15.

Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats.

Zhu W, Mix E, Nennesmo I, Adem A, Zhu J.

Exp Neurol. 2004 Dec;190(2):486-94.

PMID:
15530887
16.

Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome.

Zhu J, Mix E, Link H.

J Neuroimmunol. 1998 Apr 1;84(1):40-52. Review.

PMID:
9600707
17.

Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis.

Bao L, Lindgren JU, Zhu Yu, Ljunggren HG, Zhu J.

Neurobiol Dis. 2003 Feb;12(1):73-81.

PMID:
12609491
18.

Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.

Kumral A, Baskin H, Yesilirmak DC, Ergur BU, Aykan S, Genc S, Genc K, Yilmaz O, Tugyan K, Giray O, Duman N, Ozkan H.

Neonatology. 2007;92(4):269-78. Epub 2007 Jul 11.

PMID:
17627093
19.

Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules.

Meyer zu Hörste G, Mausberg AK, Müller JI, Lehmann HC, Löber S, Gmeiner P, Hartung HP, Stüve O, Korth C, Kieseier BC.

PLoS One. 2011;6(6):e21223. doi: 10.1371/journal.pone.0021223. Epub 2011 Jun 16.

20.

Differential susceptibility to experimental autoimmune neuritis in Lewis rat strains is associated with T-cell immunity to myelin antigens.

Zhu W, Zhang K, Mix E, Wang X, Adem A, Zhu J.

J Neurosci Res. 2011 Mar;89(3):448-56. doi: 10.1002/jnr.22541. Epub 2010 Dec 22.

PMID:
21259331
Items per page

Supplemental Content

Write to the Help Desk